Login
$HRZN
$3.95 +$0.01 (0.13%) Live

Consolidated Statements of Assets and Liabilities (Current Period Unaudited)

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Assets
Investments at fair value
Investment, Unaffiliated Issuer
Investment, Affiliated Issuer, Noncontrolled
Investment, Affiliated Issuer, Controlled
Total investments at fair value
Cash
Investments in money market funds
Restricted investments in money market funds
Interest receivable
Other assets
Total assets
Liabilities
Borrowings (Note 7)
Distributions payable
Base management fee payable (Note 3)
Incentive fee payable (Note 3)
Other accrued expenses
Total liabilities
Net assets
Preferred stock, par value $0.001 per share, 1,000,000 shares authorized, zero shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, par value $0.001 per share, 100,000,000 shares authorized, 68,511,552 and 45,781,280 shares issued and 66,978,865 and 45,613,815 shares outstanding as of June 30, 2026 and December 31, 2025, respectively
Paid-in capital in excess of par
Distributable loss
Total net assets
Total liabilities and net assets
Net asset value per common share (in dollars per share)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support